1. Home
  2. MYFW vs MDWD Comparison

MYFW vs MDWD Comparison

Compare MYFW & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MYFW

First Western Financial Inc.

HOLD

Current Price

$26.66

Market Cap

255.0M

Sector

Finance

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$16.31

Market Cap

238.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYFW
MDWD
Founded
2002
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
255.0M
238.5M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
MYFW
MDWD
Price
$26.66
$16.31
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$24.25
$37.50
AVG Volume (30 Days)
28.3K
96.5K
Earning Date
01-22-2026
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
391.62
N/A
EPS
1.28
N/A
Revenue
$95,514,000.00
$20,932,000.00
Revenue This Year
$15.96
$15.89
Revenue Next Year
$13.77
$25.33
P/E Ratio
$20.87
N/A
Revenue Growth
19.92
6.15
52 Week Low
$17.52
$14.14
52 Week High
$28.00
$22.51

Technical Indicators

Market Signals
Indicator
MYFW
MDWD
Relative Strength Index (RSI) 62.62 34.52
Support Level $25.58 $16.32
Resistance Level $26.98 $19.70
Average True Range (ATR) 1.04 0.78
MACD -0.04 -0.26
Stochastic Oscillator 48.67 2.46

Price Performance

Historical Comparison
MYFW
MDWD

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: